CLINICAL_TRIALS
ClinicalTrials.gov record update
A Feasibility Study Using the CliniMACS® Device for T-Cell Receptor (TCR) αβ+CD3+/CD19+ Depleted Hematopoietic Stem Cells for Patients Undergoing Transplant
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05968170
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:35.625370+00:00
- Published At
- 2025-07-14T00:00:00+00:00
- Record Updated At
- 2025-07-14
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Graft Vs Host Disease", "Graft-versus-host-disease", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Non-hematologic Malignancy", "Hematologic Malignancy"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-14"- protocolSection.identificationModule.nctId
"NCT05968170"- protocolSection.identificationModule.officialTitle
"A Feasibility Study Using the CliniMACS\u00ae Device for T-Cell Receptor (TCR) \u03b1\u03b2+CD3+/CD19+ Depleted Hematopoietic Stem Cells for Patients Undergoing Transplant"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.